Enhancement of angiogenesis by endogenous substance P release and neurokinin-1 receptors during neurogenic inflammation

Journal of Pharmacology and Experimental Therapeutics

Volumn 306, Issue 1, 2003, Pages 8-12

  Seegers, Hélène C ^a   Hood, Vivienne C ^a,b   Kidd, Bruce L ^b   Cruwys, Simon C ^b,c   Walsh, David A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; NOLPITANTIUM; RECEPTOR SUBTYPE; SUBSTANCE P;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ENDOTHELIUM CELL; LABELING INDEX; NEUROGENIC INFLAMMATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PERIPHERAL NERVE; PHASE TRANSITION; PRIORITY JOURNAL; RAT; SENSORY NERVE; SYNOVIUM; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIUM; KNEE JOINT; MACROPHAGES; MALE; NEOVASCULARIZATION, PATHOLOGIC; NEUROGENIC INFLAMMATION; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, WISTAR; RECEPTORS, NEUROKININ-1; SUBSTANCE P;

EID: 0037937249     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.050013     Document Type: Article

References (30)

1. Dijkstra CD, Dopp EA, Joling P, and Kraal G (1985) The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2, and ED3. Immunology 54:589-599.
2. Eglezos A, Giuliani S, Viti G, and Maggi CA (1991) Direct evidence that capsaicin-induced plasma protein extravasation is mediated through tachykinin NK1 receptors. Eur J Pharmacol 209:277-279.
3. Emonds-Alt X, Advenier C, Cognon C, Croci T, Daoui S, Ducoux JP, Landi M, Naline E, Neliat G, Poncelet M, et al. (1997) Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonist. Neuropeptides 31:449-458.
4. Emonds-Alt X, Doutremepuich JD, Heaulme M, Neliat G, Santucci V, Steinberg R, Vilain P, Bichon D, Ducoux JP, Proietto V, et al. (1993) In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Eur J Pharmacol 250:403-413.
5. Fan TP, Hu DE, Guard S, Gresham GA, and Watling KJ (1993) Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists. Br J Pharmacol 110:43-49.
6. Garrett NE, Mapp PI, Cruwys SC, Kidd BL, and Blake DR (1992) Role of substance P in inflammatory arthritis. Ann Rheum Dis 51:1014-1018.
7. Grant AD, Gerard NP, and Brain SD (2002) Evidence of a role for NK1 and CGRP receptors in mediating neurogenic vasodilatation in the mouse ear. Br J Pharmacol 135:356-362.
8. Haegerstrand A, Dalsgaard CJ, Jonzon B, Larsson O, and Nilsson J (1990) Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. Proc Natl Acad Sci USA 87:3299-3303.
9. Holzer P (1988) Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24:739-768.
10. Male D, Rahman J, Linke A, Zhao W, and Hickey W (1995) An interferon-inducible molecule on brain endothelium which controls lymphocyte adhesion mediated by integrins. Immunology 84:453-460.
11. Mapp PI, Kerslake S, Brain SD, Blake DR, and Cambridge H (1996) The effect of intra-articular capsaicin on nerve fibres within the synovium of the rat knee joint. J Chem Neuroanat 10:11-18.
12. Oury-Donat F, Lefevre IA, Thurneyssen O, Gauthier T, Bordey A, Feltz P, Emonds-Alt X, Le Fur G, and Soubrie P (1994) SR 140333, a novel, selective and potent nonpeptide antagonist of the NK1 tachykinin receptor: characterization on the U373MG cell line. J Neurochem 62:1399-1407.
13. Richardson JD and Vasko MR (2002) Cellular mechanisms of neurogenic inflammation. J Pharmacol Exp Ther 302:839-845.
14. Rupniak NM, Boyce S, Williams AR, Cook G, Longmore J, Seabrook GR, Caeser M, Iversen SD, and Hill RG (1993) Antinociceptive activity of NK1 receptor antagonists: non-specific effects of racemic RP67580. Br J Pharmacol 110:1607-1613.
15. Sanna PP, Jirikowski GF, Lewandowski GA, and Bloom FE (1992) Applications of DAPI cytochemistry to neurobiology. Biotech Histochem 67:346-350.
16. 2+ channels. Eur J Pharmacol 219:491- 492.
17. Stevens CR, Blake DR, Merry P, Revell PA, and Levick JR (1991) A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum 34:1508-1513.
18. Szallasi A and Blumberg PM (1999) Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 51:159-212.
19. Theriault E, Otsuka M, and Jessell T (1!)79) Capsaicin-evoked release of substance P from primary sensory neurons. Brain Res 170:209-213.
20. Villablanca AC, Murphy CJ, and Reid TW (1994) Growth-promoting effects of substance P on endothelial cells in vitro. Synergism with calcitonin gene-related peptide, insulin and plasma factors. Circ Res 75:1113-1120.
21. Walsh DA and Haywood L (2001) Angiogenesis: a therapeutic target in arthritis. Curr Opin Investig Drugs 2:1054-1063.
22. Walsh DA, Mapp PI, Wharton J, Rutherford RA, Kidd BL, Revell PA, Blake DR, and Polak JM (1992) Localisation and characterisation of substance P binding to human synovial tissue in rheumatoid arthritis. Ann Rheum Dis 51:313-317.
23. Walsh DA, Rodway HA, and Claxson A. (1998a) Vascular turnover during carrageenan synovitis in the rat. Lab Investig 78:1513-1521.
24. Walsh DA, Salmon M, Mapp PI, Wharton J, Garrett N, Blake DR, and Polak JM (1993) Microvascular substance P binding to normal and inflamed rat and human synovium. J Pharmacol Exp Ther 267:951-960.
25. Walsh DA, Wade M, Mapp PI, and Blake DR (1998b) Focally regulated endothelial proliferation and cell death in human synovium. Am J Pathol 152:691-702.
26. Waseem NH and Lane DP (1990) Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 96:121-129.
27. Weber AJ and De Bandt M (2000) Angicgenesis: general mechanisms and implications for rheumatoid arthritis. Joint Bone Spine 67:366-383.
28. Xu XJ, Dalsgaard CJ, Maggi CA, and Wiesenfeld-Hallin Z (1992) NK-1, but not NK-2, tachykinin receptors mediate plasma extravasation induced by antidromic C-fiber stimulation in rat hindpaw: demonstrated with the NK-1 antagonist CP-96, 345 and the NK-2 antagonist Men 10207. Neurosci Lett 139:249-252.
29. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, and Ledda F (1994) Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Investig 94:2036-2044.
30. Ziche M, Morbidelli L, Pacini M, GeppeLti P, Alessandri G, and Maggi CA (1990) Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res 40:264-278.